Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayman

Showing results (191-200 of 446) with videos related to

Pageof 45
Sort By:
Leukemia|April 12, 2022
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Leukemia|July 2, 2024
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Leukemia|September 30, 2018
Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosisJithma P Abeykoon, Saurabh Zanwar, Angela Dispenzieri, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
Blood Cancer Journal|March 21, 2015
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantationV Roy, A K Stewart, P L Bergsagel, et al.
Cancer|May 5, 2016
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Bone Marrow Transplantation|April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemiaM A Elliott, A Tefferi, W J Hogan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2009
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidneyMorie A Gertz, Nelson Leung, Martha Q Lacy, et al.
Leukemia|February 22, 2022
Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Blood|September 2, 2011
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndromeAnita D'Souza, Suzanne R Hayman, Francis Buadi, et al.
Pageof 45

Showing results (191-200 of 446) with videos related to

Sort By:
Pageof 45
Leukemia|April 12, 2022
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Leukemia|July 2, 2024
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Leukemia|September 30, 2018
Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosisJithma P Abeykoon, Saurabh Zanwar, Angela Dispenzieri, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
Blood Cancer Journal|March 21, 2015
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantationV Roy, A K Stewart, P L Bergsagel, et al.
Cancer|May 5, 2016
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Bone Marrow Transplantation|April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemiaM A Elliott, A Tefferi, W J Hogan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2009
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidneyMorie A Gertz, Nelson Leung, Martha Q Lacy, et al.
Leukemia|February 22, 2022
Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Blood|September 2, 2011
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndromeAnita D'Souza, Suzanne R Hayman, Francis Buadi, et al.
Pageof 45